Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer
Clinical trial NCT04083963 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04083963
- Sponsor
- University of Illinois at Chicago
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-09
- Primary completion
- 2026-09-27
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.